Inducing puberty

European Journal of Endocrinology

Volumn 159, Issue SUPPL. 1, 2008, Pages

  Delemarre, Eveline M ^a   Felius, Bram ^a   Delemarre Van De Waal, Henriette A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN DERIVATIVE; ESTRADIOL; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; GONADOTROPIN; GROWTH FACTOR RECEPTOR; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROTEIN KAL1; PROTEIN NROB1; PROTEIN PROP1; SEX HORMONE; TESTOSTERONE; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE; TRANSCRIPTION FACTOR LHX3; UNCLASSIFIED DRUG; ANDROGEN; DRUG DERIVATIVE; ESTROGEN; GONADORELIN;

CONFERENCE PAPER; DRUG DOSE INCREASE; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC POLYMORPHISM; GONADORELIN TEST; GYNECOMASTIA; HEREDITY; HETEROZYGOSITY; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; PATHOGENESIS; PUBERTY; SPERMATOGENESIS; DELAYED PUBERTY; FEMALE; HYPOGONADISM; MALE; PATHOPHYSIOLOGY; REVIEW; SECRETION;

ANDROGENS; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; HYPOGONADISM; MALE; PUBERTY, DELAYED; TESTOSTERONE;

EID: 58749098430     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0314     Document Type: Conference Paper

References (48)

1. Wennink JM, Delemarre-Van de Waal HA, van Kessel H, Mulder GH, Foster JP & Schoemaker J. Luteinizing hormone secretion patterns in boys at the onset of puberty measured using a highly sensitive immunoradiometric assay. Journal of Clinical Endocrinology and Metabolism 1988 67 924-928.
2. Wennink JM, Delemarre-Van de Waal HA, Schoemaker R, Schoemaker H & Schoemaker J. Luteinizing hormone and follicle stimulating hormone secretion patterns in boys throughout puberty measured using highly sensitive immunoradiometric assays. Clinical Endocrinology 1989 31 551-564.
3. Yen SS, Tsai CC, Naftolin F, Vandenberg G & Ajabor L. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. Journal of Clinical Endocrinology and Metabolism 1972 34 671-675.
4. Yen SC, Llerena LA, Pearson OH & Littell AS. Disappearance rates of endogenous follicle-stimulating hormone in serum following surgical hypophysectomy in man. Journal of Clinical Endocrinology and Metabolism 1970 30 325-329.
5. Wennink JM, Delemarre-van de Waal HA, Schoemaker R, Schoemaker H & Schoemaker J. Luteinizing hormone and follicle stimulating hormone secretion patterns in girls throughout puberty measured using highly sensitive immunoradiometric assays. Clinical Endocrinology 1990 33 333-344.
6. Boyar RM, Wu RHK, Roffwarg S, Kapen S, Weitzman ED, Hellman L & Finkelstein JW. Human puberty: 24-hour estradiol pattern in pubertal girls. Journal of Clinical Endocrinology and Metabolism 1976 43 1418-1421.
7. Delemarre-Van deWaal HA. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism - diagnostic and therapeutic aspects. European Journal of Endocrinology 2004 151 U89-U94.
8. Kauschansky A, Dickerman Z, Phillip M, Weintrob N & Strich D. Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys. Clinical Endocrinology 2002 56 603-607.
9. Mul D, Fredriks AM, van Buuren S, Oostdijk W, Verloove-Vanhorick SP &Wit JM. Pubertal development in The Netherlands 1965-1997. Pediatric Research 2001 50 479-486.
10. Evain-Brion D, Gendrel D, Bozzola M, Chaussain JL & Job JC. Diagnosis of Kallmann's syndrome in early infancy. Acta Paediatrica Scandinavica 1982 71 937-940.
11. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Milasseau P, Le Paslier D, Cohen D & Caterina D. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991 67 423-435.
12. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C & Hardelin JP. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nature Genetics 2003 33 463-465.
13. Seminara SB, Achermann JC, Genel M, Jameson JL & Crowley WF Jr. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. Journal of Clinical Endocrinology and Metabolism 1999 84 4501-4509.
14. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA & Colledge WH. The GPR54 gene as a regulator of puberty. New England Journal of Medicine 2003 349 1614-1627.
15. Cohen LE & Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocrine Reviews 2002 23 431-442.
16. Osorio MG, Marui S, Jorge AA, Latronico AC, Lo LS, Leite CC, Estefan V, Mendonca BB & Arnhold IJ. Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. Journal of Clinical Endocrinology and Metabolism 2002 87 5076-5084.
17. Riepe FG, Partsch CJ, Blankenstein O, Monig H, Pfaffle RW & Sippell WG. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. Journal of Clinical Endocrinology and Metabolism 2001 86 4353-4357.
18. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A & Amselem S. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genetics 2000 25 182-186.
19. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS & Robinson IC. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics 1998 19 125-133.
20. de Lind van Wijngaarden RF, Otten BJ, Festen DA, Joosten KF, de Jong FH, Sweep FC & Hokken-Koelega AC. High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2008 93 1649-1654.
21. Paterson WF & Donaldson MD. Growth hormone therapy in the Prader-Willi syndrome. Archives of Disease in Childhood 2003 88 283-285.
22. Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Gruters A & Simoni M. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2006 91 892-898.
23. Muller J. Disturbance of pubertal development after cancer treatment. Best Practice and Research. Clinical Endocrinology and Metabolism 2002 16 91-103.
24. Schally AV, Arimura A, Baba Y, Nair RMG, Matsuo H, Redding TW & Debeljuk L. Isolation and properties of the FSH and LH-relesing hormone. Biochemical and Biophysical Research Communications 1971 43 393-398.
25. Wentz AC. Clinical applications of luteinizing hormone-releasing hormone. Fertility and Sterility 1977 28 901-912.
26. Dickerman Z, Prager-Lewis R & Laron Z. Response of plasma LH and FSH to synthetic LH-RH in children at various pubertal stages. American Journal of Diseases of Children 1976 130 634-638.
27. Clarke IJ & Cummins JT. The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes. Endocrinology 1982 111 1737-1739.
28. Karten MJ & Rivier JE. Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocrine Reviews 1986 7 44-66.
29. Delemarre-van de Waal HA, Van den Brande JL & Schoemaker J. Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects. Journal of Clinical Endocrinology and Metabolism 1985 61 859-867.
30. Delemarre-van de Waal HA. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin- releasing hormone in patients with hypogonadotrophic hypogonadism. Clinical Endocrinology 1993 38 473-480.
31. Kaplan SL, Grumbach MM & Aubert ML. Alpha and beta glycoprotein hormone subunits (hLH, hFSH, hCG) in the serum and pituitary of the human fetus. Journal of Clinical Endocrinology and Metabolism 1976 42 995-998.
32. Verhoeven G & Cailleau J. A Leydig cell stimulatory factor produced by human testicular tubules. Molecular and Cellular Endocrinology 1987 49 137-147.
33. Fritz MA & Speroff L. The endocrinology of the menstrual cycle: the interaction of folliculogenesis and neuroendocrine mechanisms. Fertility and Sterility 1982 38 509-529.
34. Thorsson AV, Christiansen P & Ritzen M. Efficacy and safety of hormonal treatment of cryptorchidism: current state of the art. Acta Paediatrica 2007 96 628-630.
35. Okada Y & Onishi T. Pubertal growth spurt induced by human chorionic gonadotropin in hypogonadotropic growth hormone-deficient children. Endocrinologia Japonica 1989 36 695-703.
36. Matsumoto AM. Hormonal therapy of male hypogonadism. Endocrinology and Metabolism Clinics of North America 1994 23 857-875.
37. Finkel DM, Phillips JL & Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. New England Journal of Medicine 1985 313 651-655.
38. Ley SB & Leonard JM. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. Journal of Clinical Endocrinology and Metabolism 1985 61 746-752.
39. Burris AS, Clark RV, Vantman DJ & Sherins RJ. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertility and Sterility 1988 50 343-347.
40. Barrio R, de Luis D, Alonso M, Lamas A & Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertility and Sterility 1999 71 244-248.
41. Schopohl J, Mehltretter G, von Zumbusch R, Eversmann T & von Werder K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy inmale patientswith idiopathic hypothalamic hypogonadism. Fertility and Sterility 1991 56 1143-1150.
42. Buchter D, Behre HM, Kliesch S & Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology 1998 139 298-303.
43. Liu L, Banks SM, Barnes KM & Sherins RJ. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 1988 67 1140-1145.
44. Thau RB, Goldstein M, Yamamoto Y, Burrow GN, Phillips D & Bardin CW. Failure of gonadotropin therapy secondary to chorionic gonadotropin-induced antibodies. Journal of Clinical Endocrinology and Metabolism 1988 66 862-867.
45. Burger HG. Physiological principles of endocrine replacement: estrogen. Hormone Research 2001 56 (Suppl 1) 82-85.
46. Delemarre-Van deWaal HA. In Growth Disorders, pp 595-608. Eds CJH Kelnar, MO Savage, P Saenger & CT Cowell, London: Edward Arnold Ltd, 2007.
47. Guttmann H, Weiner Z, Nikolski E, Ish-Shalom S, Itskovitz-Eldor J & Aviram M. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clinical Endocrinology 2001 54 159-164.
48. Pozo J & Argente J. Ascertainment and treatment of delayed puberty. Hormone Research 2003 60 (Suppl 3) 35-48.